Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dergunov
NCT05654454: A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer	Recruiting	3	620	RoW	Bevacizumab, Paclitaxel, Carboplatin	Mabscale, LLC	Non-Small Cell Lung Cancer	12/26	03/27
Mancirev
NCT05654454: A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer	Recruiting	3	620	RoW	Bevacizumab, Paclitaxel, Carboplatin	Mabscale, LLC	Non-Small Cell Lung Cancer	12/26	03/27
Sakaeva
NCT05654454: A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer	Recruiting	3	620	RoW	Bevacizumab, Paclitaxel, Carboplatin	Mabscale, LLC	Non-Small Cell Lung Cancer	12/26	03/27